SB-203207 and 10 analogues have been prepared, by elaboration of altemicidi
n, and evaluated as inhibitors of isoleucyl, leucyl and valyl tRNA syntheta
ses (IRS, LRS, and VRS, respectively). Substituting the isoleucine residue
of SB-203207 with leucine and valine increased the potency of inhibition of
LRS and VRS, respectively. The leucine derivative showed low level antibac
terial activity, while several of the compounds inhibited IRS from Staphylo
coccus aureus WCUH29 more strongly than rat liver IRS. (C) 2000 Elsevier Sc
ience Ltd. All rights reserved.